CribMD acquires Charisland Pharmaceuticals to facilitate enhanced drug deliveries

NIGERIA – CribMD, a Nigerian healthtech startup, has announced its acquisition of Charisland Pharmaceuticals Group to ensure fast and efficient drug deliveries to its customers across Nigeria. Charisland Pharmaceuticals Group was founded nine years ago and has a presence in major Nigerian cities. With the Group’s decision to exit the Nigerian market and expand into Canada, CribMD’s acquisition of the pharmaceutical chain, as opposed to building a solution in-house, will see it leverage the company’s vast network of pharmacies to deliver drugs faster to their subscribers. The acquisition comes on…

Read More